Asthma or Chronic Rhinosinusitis with Nasal Polyps Patient Survey
COPD Patient and Caregiver patient advisory board
Chronic Urticaria (different opportunities)
Asthma Patients focus group
Non-Cystic-Fibrosis Bronchiectasis Patient Advisory Board for Clinical Trial Protocol Feedback
Short Interview for Speak-up for COPD Coalition
GAAPP Publications
From the Chief Scientific Officer Desk
Opportunities
Asthma or Chronic Rhinosinusitis
with Nasal Polyps Survey.
We’re listening to you! If you’re living with asthma or chronic rhinosinusitis with nasal polyps and reside in the US, Canada, UK, Germany, Italy, France, or Spain, your insights are invaluable. Join our survey and contribute to developing better educational materials for patients and providers.
This month, we have many paid opportunities for patients to get involved and meaningfully contribute to research opportunities and patient advisory boards. All opportunities are paid at a fair market price for each participant’s country.
Let us know if you or someone in your community is a good match for any of these:
Opportunity 1: COPD Patient and Caregiver patient advisory board
3-4 online engagements during 2024.
Looking for a COPD caregiver in Asia.
Inclusion criteria: Can speak basic English, adult.
Inclusion criteria: Adult, can speak basic English, French, or Spanish. All regions.
Opportunity 5: Short Interview for Speak-up for COPD Coalition
Virtual 45-minute interview.
Looking for COPD patients from Malaysia, China, Saudi Arabia and Belgium.
Inclusion criteria: Adult, can speak basic English (If cannot speak English, a written option will be offered).
If you are interested in participating in any of these opportunites, please contact us at info@gaapp.org
GAAPP Publications
GAAPP has co-authored multiple-recent peer-reviewed publications. Please visit our website to check those publications and also access the latest guidelines from GINA, GOLD, EADV, AAI, and EAACI.
A recent Publication co-authored by our CSO highlights common features in age-related diseases: COPD, bronchiectasis, abdominal aortic aneurysm, and rheumatoid arthritis.
In this newsletter we invite you to seize numerous opportunities to get involved, ensuring patient and caregiver voices are heard and valued throughout global collaborative endeavors.
The CAAT™ Governance Board resolved to rename CAT ™ ( the COPD Assessment Test) to CAAT™ representing its application in chronic airways conditions beyond COPD. The CAAT website (https://gaapp.org/caat-cat/) includes a revised User Guide and Implementation Guide for CAAT users. Sponsors of new studies are encouraged to use the CAAT but existing studies/systems should continue to use the CAT during the transition period before Regulatory agencies are informed.
We are grateful to Phyliss DiLorenzo a COPD patient advocate describing her experience using the CAT to manage her health. Check our her story here.
